In the study: "Effects of human-animal interaction on salivary and urinary oxytocin in children and dogs1", oxytocin levels were recorded in 55 children and their pet dogs.
Oxytocin is associated with positive emotions, the reduction of stress and the formation of social bonds.
Oxytocin levels were tracked in both the children’s and dogs’ urine and saliva before and after they interacted.
Researchers say this is one of the first studies to examine the benefits of human animal interactions for both humans and dogs.
For the study, the children's oxytocin levels were measured when they interacted with their own pet dog, with an unfamiliar dog (a trained therapy dog), and when they engaged in solitary play.
The study found that:
The researchers concluded that the results support the hypothesis that oxytocin pathways may shape and respond to social interactions between children and dogs, highlighting an important role for companion animals in child development.
https://www.waltham.com/oxytocin-children-and-dogs
Reference
Francesca's initiative was recognised with a RCVS Knowledge ‘Highly Commended’ status at its 2024 awards.
The idea for the audit came about after Francesca noticed a trend for patients to become hypotensive during anaesthesia for routine feline neutering and need additional treatment.
CVS says clinical evidence suggests a minimum value of 60mmHg for perfusion of vital organs such as the brain, heart and kidneys.
So a clinical audit was undertaken to look at perioperative blood pressure in both cats and dogs having routine neutering procedures.
The target was for patients to maintain a mean arterial blood pressure of 60mmHg during their anaesthetic.
The animals chosen for auditing were to be classed ASA 1 and under 5 years old.
They received a pre-operative health check including a blood pressure reading to ensure they were normotensive.
A first audit looked at a standard premedication protocol of ACP at a dose rate of 0.02mg/kg combined with methadone at a dose rate of 0.3mg/kg.
A second audit initiated a change to the pre-medication drugs, using 0.005mg/kg medetomidine combined with the same dose of methadone.
Both received anaesthesia induction with Propoflo at a dose rate of 6mg/kg for cats and 4mg/kg for dogs.
All patients under anaesthetic were maintained using isoflurane and kept at a surgical plane of anaesthesia appropriate for that patient.
The patients were monitored throughout their surgical procedure using an oscilliometric monitoring machine - for systolic, diastolic and mean arterial blood pressure – and measurements recorded on an anaesthetic chart.
The collected data revealed that in the first audit, where patients received ACP and methadone, 42% (50% of cats and 38% of dogs) had a mean arterial blood pressure lower than 60mmHg after the first five blood pressure readings post induction.
In the second audit, with medetomidine combined with methadone, only 11% of patients (0% of cats and 15% of dogs) with a mean arterial blood pressure lower than 60mmHg.
In addition to the reduction in hypotensive patients during anaesthesia when the medetomidine/methadone combo was used, Francesca says the audit suggests a link to hypotension with ACP used as a premedication in anaesthetised patients.
Francesca said: “My passion in veterinary nursing is anaesthesia. And there is always room for improvement and striving to achieve gold standard care.
“These results clearly show that a change from our current premedication protocol of ACP and Methodone to Medetomidine and Methadone decreased the number of patients having hypotension during anaesthesia. The change means fewer patients were at risk of developing the side effects associated with hypoperfusion of the vital organs.
“Our quality improvement initiative has made a really positive impact in practice for both patient care and clinical team.”
The webinar will cover the entire disease process of MMVD in dogs from pathology to current treatment approaches and future advancements in therapy, and will include the following presentations:
https://us06web.zoom.us/webinar/register/WN_QyfUofLgRG-YsaXQbkT7Tw#/registration
Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.
Furosoral replaces Dechra’s previous diuretic treatment, Frusedale.
It is available in both 10 mg and 40 mg double-divisable tablets.
The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.
Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.
Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.
“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”
Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.
https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/.
The announcement came hot on the heels of announcements from Ceva and Boehringer that they too had vaccines in the pipeline.
Syvazul BTV3 is licensed to reduce viraemia, prevent mortality and reduce clinical signs and lesions in sheep and for the active immunisation against bluetongue virus serotype 3 in cattle.
Like all vaccines currently available for this serotype, the vaccine will not prevent infection and vaccinated animals will still be subject to bluetongue movement controls and trade restrictions currently in place.
Administered as a single 2ml dose subcutaneously in sheep and as two 4ml intramuscular doses 3 weeks apart in cattle, Syvazul BTV3 contains inactivated Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023.
The vaccine is licenced for use during pregnancy and lactation in both sheep and cattle.
The onset of immunity is 28 days after the primary vaccine in sheep. A single booster revaccination dose of 2ml for sheep and 4ml for cattle is recommended after 12 months.
Presented in two pack sizes, 80ml and 200ml, Syvazul BTV3 vaccine has a shelf life of 2 years from manufacture and a broach life of 10 hours.
Licensing for use will be geographic, based upon high risk counties or by specific licence from the APHA.
Bluevac-3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3 for use in sheep and cattle.
Ceva says it reduces viraemia, prevents mortality and reduces the clinical signs of BTV-3 in sheep and reduces viraemia in cattle.
In sheep, Bluevac-3 can be administered from two months of age and two doses of 2ml should be administered subcutaneously three weeks apart.
In cattle, the vaccine can be administered from two months of age and two doses of 4ml should be administered three weeks apart.
Onset of immunity occurs 21 days/three weeks after completion of primary vaccination in cattle and sheep.
The vaccine can be used in pregnancy in cows and ewes.
No negative impact on milk-yield after using the vaccine in lactating ewes and cows is expected.
Ceva developed the new vaccine in partnership with vaccine manufacturer CZV Vaccines and launched it in Europe early in the summer, to mitigate the impact of the disease already experienced in the Netherlands, Belgium, and Germany.
Craig Wright, ruminant business unit director at Ceva Animal Health, said: “In co-operation with our partner, CZV Vaccines, we have worked tirelessly to bring Bluevac-3 to the UK to help fight bluetongue which has the potential to cause severe financial loss to farmers.
"The availability of an effective vaccine is an essential tool to help suppress future outbreaks by reducing viraemia, preventing mortality and reducing the clinical signs of BTV-3.”
Licences to allow the use of the new vaccine will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA.
General licencing will be subject to risk assessment.
https://www.gov.uk/government/publications/summary-of-product-characteristics-for-bluevac-3-btv-3-vaccine-in-the-uk.
According to the NFU, last year farm animals worth an estimated £2.4 million pounds were severely injured or killed by dog attacks last year.
Obtaining forensic samples after an attack can be difficult because so often they happen in remote places and rural police can't always attend quickly enough to get a sample.
Dr. Nick Dawnay from Liverpool John Moores University therefore developed Early Evidence Kits to enable samples to be collected by vets, famers and police from the crime scene immediately.
Following a successful proof of concept in Wales, the research team is now trialling the kits in ten regions of England and Wales, with support from IVC Evidensia farm practices.
Over the next twelve months the trial will refine best practices for collecting forensic samples from livestock attack scenes.
David Martin, Group Head of Animal Welfare at IVC Evidensia said: “This project marks an exciting step forward in collecting and analysing canine DNA from livestock.
"It offers police and farmers a means to hold irresponsible dog owners culpable for the damage and losses caused by their pets.”
“As a profession we can support this research by ensuring samples are taken from as many cases within the relevant force areas as possible so that the team at John Moores gets sufficient material to be able to complete this project as soon as possible.
"All IVC Evidensia farm practices in the participating regions are being encouraged to use the kits and we want to ensure all farm practices in those regions know about this important project.”
It is hoped new legislation for England and Wales will be brought in to give police officers the power to take a DNA sample from a suspected dog to compare to canine DNA left at an attack scene.
Dave Allen, North Wales Police and NPCC Livestock Offence Working Group Secretary said: “These kits are an exciting development and can be utilised for an issue that causes major concern to our UK rural communities”.
Veterinary practices are now being encouraged help raise awareness of the project, particularly to encourage farmers to take part and use the kits to collect evidence in the following regions:
https://www.ljmu.ac.uk/about-us/news/articles/2024/5/17/forensic-science-to-help-farmers-foil-sheep-attacks
Vetlife's campaign included talks at various veterinary events, an awareness video, a series of lived experience blogs, and a downloadable resource for individuals and workplaces, all made possible by grant funding from the Zoetis Foundation.
Kirstie Pickles, Vetlife Trustee and project lead for the neurodiversity campaign said: “To be shortlisted was an honour, but to win this award is just incredible and is a testament to the dedication and passion that the team put into the campaign.
"It has been a pleasure and a privilege to lead this project and share this much needed information with the veterinary community.
"It is our hope that this campaign and its resources will enable and initiate discussions within teams to ensure that all within our wonderful veterinary professions can thrive."
https://www.vetlife.org.uk
The new resources include:
Celia Marr, chair of BEVA’s infectious disease working group, said: “Equine disease prevention and management are fundamental for responsible equine health, welfare and performance.
“These resources cover the need-to-know information and are all in one easy reverence location on the newly designed infection control page on the BEVA website.”
https://www.beva.org.uk/Resources/Equine-infectious-diseases
The session is designed for business owners who are considering succession planning and who may be interested in exploring alternative ownership structures.
Speakers include Jeff Lermer from JLA Accountants and Victoria Dorman from HCRLaw, both of whom have helped companies transition to employee ownership.
Matt Flann from Pennards Vets (pictured) will add the perspective of a business that has transitioned to being an Employee Owned Trust.
The session will cover the structure of Employee Ownership Trusts, the benefits of transitioning (including tax incentives) and the legal, financial and operational considerations.
The webinar was also offer practical guidance on the steps and timelines for implementing an EOT in your organization.
https://spvs.org.uk/employee-ownership-trusts-cpd
Charlie says that uniquely, the company offers feedback about samples submitted, with the aim of teaching veterinary staff the skills needed to interpret future samples themselves.
Cytovet is aimed at nurses and new grads who want to improve their cytology skills, vets who don’t have time to look at their own samples or have a tricky case they would like an additional opinion on, and those vets whose clients can’t afford the prices the big labs quote.
Charlie said: "I’m a vet with 16 years of clinical experience and a certAVP which focussed on small animal medicine and clinical pathology.
"I currently work in first opinion charity practice and have examined thousands of cytology samples over the years.
"I have been writing cytology reports for the practices I have worked for since 2012.
"I believe all vets and nurses should have the basic microscope skills required to help make more informed decisions for their patients, particularly in a world of escalating veterinary costs and antimicrobial resistance.
"I can examine both digital images and posted slides using a top-of-the-range trinocular digital microscope.
"All you need to do is submit the patient information and slides to me (digital images or actual slides) via my website and I will provide you with a report within 3-5 days."
Urgent turnaround is also available.
www.cytovet.co.uk
Nominated by a colleague, Will graduated and joined the practice in 2021, having previously worked as a dairy herdsperson.
In his nomination, clients described Will as having an excellent understanding of the practicalities of running a herd, and said he provides realistic and achievable advice.
The judging panel was impressed by Will’s dedication to improving health, welfare, and productivity on dairy farms with his clear advice and workable action plans.
In addition, Will set up an embryo transfer service, bringing a new service to his practice, along with a robot discussion group, all of which have made a significant and positive impact to his dairy farming clients.
Will said: “It was a real privilege to be awarded the Young Dairy Vet of the Year award amongst so many talented and dedicated farm vets in our line of work.
"Above all it is a testimony to the farmers I work with day to day and the proactive attitude they take to improving their systems which has given me so many opportunities to develop my career”.
This year’s runner up was Hana Ward of Torch Vets in Barnstaple, Devon.
Photo: Will with last year's winner, Tom Warboys.
The materials include a social media toolkit and a board kit, both designed to encourage owner awareness and more frequent conversations on eye health.
There is also a new CPD module, focused on ophthalmology.
The company is running a webinar on 24th September which focuses on management of dry eye and corneal ulcers for brachycephalic dogs
Campaign materials & VPD module: https://www.tvm-uk.com/national-pet-eye-health-awareness-week
Webinar: https://thewebinarvet.com/webinars/take-a-closer-look-big-eyes-big-problems-ocular-issues-of-the-brachycephalic
With 2024 support payments for farmers in England now at half former levels and significant changes to subsidies for farmers in Scotland and Wales set to come into play next year, Elanco says effective flock health management to maximise efficiency and performance within flocks has become increasingly important.
Elanco's Ruminant Technical Consultant, Matt Colston MRCVS said: “Policymakers recognise the importance of animal health and welfare for better productivity and are putting an increasing onus on vets to deliver improvements, for example via the Animal Health and Welfare Pathway (AHWP).”
“Its crucial vets have the knowledge and confidence to support sheep clients on important flock health issues, with worming programmes high up on this agenda.”
"By developing farm-specific worm control strategies and working closely with clients to better monitor worm burdens, you can help achieve immediate flock performance benefits and manage the longer term risks of anthelmintic resistance on that farm.”
Elanco says that by dosing lambs with its newer Group 4 wormer, Zolvix, at the right time during the mid to late grazing season, farmers can clear out any resistant worms that have survived previous treatments and see an uplift in daily liveweight gain as a result.
Matt added: “We shouldn’t wait for problems to manifest.
"By the time wormer groups have stopped working, or clinical signs of worms are visible, damage is already done; regular monitoring and early intervention is a better option.
“More farmers are Faecal Egg Counting (FEC) but many are unsure how best to go about it.
“A practical demonstration of how to collect samples, and what to collect from which animals, is often the best way to show how easy FEC can be.”
“Farmers can be cautious about change, but by taking small steps and consistently offering sound, practical advice, vets can help farmers adopt more sustainable worm control strategies and improve margins in sheep production.”
The Clinical Abstracts provide an opportunity to present new research to the wider veterinary community at Congress and Expo 2025, taking place at Manchester Central on 20th - 22nd March 2025.
Abstracts can be on any veterinary subject, whether it’s the preliminary results of a new study, a discussion of a new technique or a description of an interesting case.
Each application should be based on high-quality clinical research undertaken in industry, practice or academia, and summarised in 250 words.
Applications are welcome from veterinary surgeons, nurses, practice managers and students, with applications from those working in general practice especially encouraged.
Researchers with research of direct relevance to veterinary practice may also submit an abstract for consideration.
Andy Green, Chair of BSAVA’s Congress Committee said: “This is a fantastic opportunity for veterinary professionals to showcase their research to the global veterinary community, and a chance for delegates to learn about the latest concepts and thinkings in veterinary medicine from their peers.”
Entries for the Clinical Abstracts will close on Monday 18th November.
https://www.bsavacongress.com/clinical-abstracts
The project was 'highly commended' at the RCVS Knowledge 2024 awards.
The CVS clinical improvement project found that a major barrier to conducting ultrasound scans was a lack of confidence - both in using equipment and interpreting images.
A recent Canadian industry study has also reviewed barriers, citing a lack of equipment, training and skills as root causes1.
The ultrasound project aimed to review practice equipment, improve clinician case identification, increase clinical skills and confidence, and recommend ultrasound in all appropriate cases.
The company put together resources for vets and nurses designed to help improve ultrasound scan rates, including clinical guidelines, webinars for how to approach cases, and machine guides.
CVS then held training sessions which for vets focussed on case identification and improving diagnostic skills, and for vet nurses looked at how to use ultrasound equipment and conduct scans.
An audit of each participating practices’ ultrasound scan rates was conducted at the start of the project. Results were then shared with each practice every month.
Twelve months after launch, data shows that the number of ultrasound scans has increased by 3,675.
Anecdotal evidence has also shown that colleague confidence and practice team culture has improved as a result of the project.
Dr Victoria Woods, Regional Clinical Lead at CVS responsible for the ultrasound clinical improvement project, said: “It’s fantastic to see the benefits increased ultrasonography is already bringing to our practices on this project – especially as a result of upskilling our nurses.
"I am certain that this will help contribute towards them providing some of the best clinical diagnosis and care in our profession.”
Following the success of the project in its first year, the project is now being developed to focus on echocardiograph and is being undertaken in 52 CVS primary care practices in year two.
The streams for vets will include six lectures on topics ranging from neurology to dentistry, along with guest speaker Hannah Donovan from Donovan Veterinary Behaviour to discuss behaviour in practice.
There will also be a speaker from Davies’ charity of the year: Vetlife.
Davies' hospital director Ben Orton said: “This is a high-level CPD and networking event aimed at our colleagues in the veterinary industry with a raft of advice and insight from some of the leading specialists here at Davies.
“Some of the topics covered include internal medicine, with EBVS European specialist in small animal internal medicine Katherine Clarke giving her expert opinion on chronic enteropathies with a focus on antibiotic prescribing.
“Head of anaesthesia Frances Downing will focus on anaesthesia and feline cardiomyopathies while head of physiotherapy Diane Messum will discuss a holistic approach to the osteoarthritis patient, so there will be plenty of stimulating and challenging content.”
The day-long event begins at 8.30am with arrival drinks and pastries before the morning session, which runs from 9am to 1.20pm.'
After an hour’s break for lunch and networking, the afternoon session will run from 2.20pm to 5pm.
That will be followed by a complimentary hog roast.
www.vetspecialists.co.uk/davies-congress-2024
Christian Mauricio Gómez Álvarez, founder of VetCam Specialists, said: "This partnership represents a significant step forward in continuing professional development as our participants will receive first-class content and well-prepared,interactive case studies where they can additionally work directly.”
In addition, Veheri offers free access to a global community, where veterinary surgeons can share and discuss diagnostic images and imaging studies.
The company also offers a teleradiology reporting service.
The first joint training courses will be available from November 2024.
vetcameducation.com
www.veheri.com
Charlotte will share practical advice on achieving successful transfusions, in particular looking at how to overcome the challenges in sourcing blood products, especially for feline patients.
The presentation will cover:
There'll be a live Q&A session with Charlotte at the end, when Horiba's experts will also be available to answer veterinary diagnostics-related questions.
https://horiba.link/canine-and-feline-blood-transfusions.
As part of the campaign, vets are invited to share their top tips for maintaining a calm workplace for staff and patients at: https://www.nvsweb.co.uk/products/big-chill.
Veterinary professionals are being asked to share their top tips in two areas. Firstly, on how they prioritise self-care for themselves and teammates, and secondly, on how they best deal with nervous, stressed or anxious patients.
All respondents will be entered into a prize draw for a VetYogi practice subscription.
Gemma Vardy, Senior Category Specialist at NVS Group, said: “Mental health and wellbeing have never been more important within the veterinary industry which is why our dedicated Big Chill campaign supports the wellbeing and mental health of veterinary professionals while also shining a light on animal calming products, such as our select healthcare calming chews, which help support calm and enhance patient experiences.”
https://www.nvsweb.co.uk/products/big-chill
As well as raising awareness of suicide and mental health, Maria Mylne, Mary Hall, Callum McRoberts and Kirsty's partner Chris Burn are raising money for two charities: Vetlife and The Canmore Trust.
The Canmore Trust was set up by the parents of another vet who took his own life, and works with individuals, communities, practices, workplaces, schools, colleges and universities that have been affected by suicide, as well as trying to prevent suicide.
The four vets will set off from Land’s End on September 23rd and will arrive in John O’Groats on October 18th.
On the way, they will be stopping off at Bristol, Harper Adams and Keele, Liverpool, University of Central Lancashire, Edinburgh and Glasgow vet schools to speak to students about suicide prevention.
Kirsty was a trusted and respected colleague and vet, and her death had a devastating impact on her partner and colleagues who are fundraising in her memory.
Maria said: “We want to share a message of hope that suicide is not inevitable, and just because somebody has experienced suicidal thoughts, does not mean they will feel this way forever.
"Together we can break the cycle of suicide and keep building suicide safer communities in practice.”
Chris said: “Kirsty was my rock. If you wanted something organised or something fixed, Kirsty was your woman.
"We don't want anybody else to go through the pain we have.
"We want everybody to know that no matter what your mind may tell you, the world is better with you here, in this world.”
www.justgiving.com/team/lejogawareness
https://www.facebook.com/profile.php?id=61559943272380
https://www.instagram.com/lejog_awareness2024
https://thecanmoretrust.co.uk
https://www.instagram.com/the_canmore_trust
lejogawareness@gmail.com
They include a webinar from In Communication, a company which specialises in veterinary client communications, which covers things like how to broach costs with clients, communicating treatment options succinctly and time-blind shared decision-making.
The Society has also published eight questions which the public may ask about the investigation, with model responses.
The resources also include a summary of the five concerns raised by the CMA, and advice about how to discuss them with practice staff.
Finally, you can download SPVS' presentation to the CMA which talks about the drivers for fee increases.
https://spvs.org.uk/cma-spvs-response
The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting over 5,000 livestock farms.
Infection of livestock with this serotype of the virus can result in severe clinical signs and high mortality rates1, significantly impacting animal health, and farming communities.
Bultavo 3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3.
Boehringer says that in sheep, Bultavo 3 has been shown to significantly reduce viraemia and prevent mortality and clinical signs associated with BTV-3 infection.
Onset of immunity occurs three weeks after administration of a single 1ml subcutaneous dose in sheep.
In cattle, two 1ml intramuscular doses are required, at a three-week interval.
Findlay MacBean, Head of Livestock, UK and Ireland at Boehringer Ingelheim, said: “It’s great news that we can support farmers and authorities in their fight against bluetongue with our new BTV-3 vaccine, Bultavo 3.
"As we have seen across Europe, and now in the UK, BTV can spread rapidly and causes considerable stress to farmers because of the significant financial impact on those affected.
The availability of Bultavo 3 means future BTV-3 outbreaks can be suppressed, helping farmers protect not only their herds, but also their livelihoods.” Oli Maxwell, BVSc BSc(Hons) MVM DipECBHM, RCVS Recognised Specialist in Cattle Health and Production and Clinical Director of Green Counties Vets said: “Farmers are justifiably concerned about BTV-3 and its incursion into the UK again this year.
"Reports from colleagues on the continent regarding the severity of clinical signs, especially in sheep are worrying.
"We have seen a huge increase in clients asking about the disease, progress on a vaccine and what this may mean for animal movements at a critical time of year.
"The availability of a safe and effective vaccine as a critical tool against a disease that we can’t reasonably prevent with biosecurity measures will be a welcome development for many.”
To manage supply and demand, use of the product will initially be subject to geographical restriction with vaccination permitted in high-risk English counties: Norfolk, Suffolk, Essex, Kent and East Sussex.
Reference:
The awards are to recognise outstanding veterinary practices that have demonstrated exceptional performance and innovation in areas crucial to the future success of the profession.
There are three categories: Leadership and Management Skills, Team and Self-Development, and Veterinary Start-Ups.
The three category winners will each win day and evening tickets to SPVS Congress 2025 on Thursday 30th January for three team members, plus overnight accommodation at the Hilton Birmingham Metropole.
Shortlisted practices will each win a book of their choice.
The deadline for submissions is Friday 18th October 2024.
https://spvs.org.uk/business-excellence-awards/
The new formula also contains crataegus, L-carnitine and magnesium taurate, and is designed to be used alongside all heart medications.
Alongside the launch of the new product, Vita has also created an infographic highlighting the common signs of heart disease in dogs.
https://vitaanimalhealth.com/common-signs-of-heart-disease
https://vitaanimalhealth.com/product/omnicardio-plus